Treatment of isolated systolic hypertension. A comparative study of felodipine, ramipril and isosorbide mononitrate in 1041 patients

Clinical Drug Investigation

Volumn 18, Issue 3, 1999, Pages 173-181

  Lohmann, F W ^a  

^a Neukölin Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FELODIPINE; ISOSORBIDE MONONITRATE; METOPROLOL; RAMIPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; EDEMA; FEMALE; GERMANY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0032873247     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199918030-00001     Document Type: Article

References (36)

1. 1. Hansson L, Hedner Th, Himmelmann A. The growing importance of systolic blood pressure. Blood Press 1998; 7: 131
2. 2. Kaplan NM. Clinical hypertension. Baltimore (MD): Williams and Wilkins, 1994
3. 3. Klaus D. Manuale hypertonologicum. Deisenhofen: Dustri-Verlag Dr. Karl Feistle, 1997
4. 4. Lohmann FW. Hypertoniebedingte Organschäden. Versicherungsmedizin 1998; 35: 169
5. 5 Philipp Th, Distler A. Hypertonie 97 - richtlinien in diagnostik und therapie. Nieren Hochdruckkr 1997; 26: 3
6. 6. Scholze J. Hypertonie. Berlin-Wien: Blackwell Wissenschaftsverlag, 1997
7. 7. Swales JD. Textbook of hypertension. Oxford, London, Edinburgh: Blackwell Scientific Publications, 1944
8. 8. De Luca N, Pancera P, Savi P. Pulse wave velocity: an index of arterial distensibility. High Blood Press 1997; 6: 41
9. 9. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens 1996; 14 Suppl. 5: 147
10. 10. O'Rourke MF, Avolio AP, Lee L, et al. Reduction of wave reflection is the principal beneficial action of felodipine in isolated systolic hypertension [abstract no. 2.96]. Eighth European Meeting on Hypertension; 1997 Jun: Milan. J Hypertens 1997; 15 Suppl. 4: 75
11. 11. Smulyan H, Safar ME. Systolic blood pressure revisited. J Am Coll Cardiol 1997; 29: 1407
12. 12. Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997, 278: 212-6
13. 13. Lohmann FW. Arterielle hypertonie. In: Platt D, Mutschler E, editors. Pharmakotherapie im Alter. Stuttgart: Wissenschaltliche Verlagsgesellschaft, 1999. In press
14. 14. Staessen JA, Ritz E, Faulhaber H-D, et al. Isolierte systolische Hypertonie im Alter. Dtsch Med Wochenschr 1993; 118: 554
15. 15. Tonkin A, Wing L. Management of isolated systolic hypertension. Drugs 1996; 51: 738
16. 16. Wenger NK. Preventive cardiology in the elderly. Curr Opin Cardiol 1997; 12: 195
17. 17. Sagic A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993; 329: 1912
18. 18. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64
19. 19. Hansson L, Hedner Th, Jern S. Break-through for calcium antagonists in the treatment of hypertension based on Syst-Eur results. Blood Press 1998; 7: 3-4
20. 20. Salar ME, Levy BI. Mechanical function and histological structure of the arterial wall. The response to antihypertensive treatment. Drugs 1993; 46 Suppl. 2: 68
21. 21. Asmar RG, Benetos A, Chaouche-Teyara K, et al. Comparison of effects of felodipine versus hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension. Am J Cardiol 1993; 72: 794
22. 22. Gerdes M, Lüders S, Heydenbluth R, et al. Die antihypertensive Wirksamkeit von Isosorbid-5-Mononitrat bei Patienten mit isolierter systolischer Hypertonie. Nieren Hochdruckkr 1995; 24: 126
23. 23. Staessen JA, Thijs L, Fagard RH, et al. Calcium channel blockade and cardiovascular prognosis in the European Trial on Isolated Systolic Hypertension. Hypertension 1998; 32: 410-6
24. 24. Vandewoude MFJ, Lambert M, Vryens R. Open evaluation of amlodipine in the monotherapeutic treatment of systolic hypertension in the elderly. J Cardiovasc Pharmacol 1991; 17 Suppl. 1: 28
25. 25. Webster J, Fowler G, Jeffers TA, et al. A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension. Br J Clin Pharmacol 1993; 35: 499
26. 26. Wing LM, Russel AE, Tonkin AL, et al. Mono-and combination therapy with felodipine or enalapril in elderly patients with systolic hypertension. Blood Press 1994; 3: 90
27. 27. Cleland JGF, Diez J, Dzau V, editors. Angiotensin II antagonism: a new advance in treatment of hypertension. J Hypertension Suppl. 1994; 12 (2): 1-53
28. 28. Lohmann FW. Wirksamkeit und Verträglichkeit von 16mg Candesartan bei mittelschwerer und schwerer essentieller arterieller Hypertonie. Therapickontrolle mittels ambulanter 24-Stunden-Blut-druckmessung. Perfusion 1998; 11: 424
29. 29. Mancia G, Grassi G. Antihypertensive effect of combined lisinopril and hydrochlorothiazide in elderly patients with systodiastolic or systolic hypertension: results of a multicentre trial. J Cardiovasc Pharmacol 1997; 30: 548
30. 30. Wing LM, Russel AE, Tonkin AL, et al. Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly. Blood Press 1994; 3: 82
31. 31. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255
32. 32. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62
33. 33. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Sixth Report, Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute, National High Blood Pressure Education Program. NIH Publication, November 1997
34. 34. Niarchos AP, Laragh JH. Renin dependency of blood pressure in isolated systolic hypertension. Am J Med 1984; 77: 407
35. 35. Lohmann FW, Heckert C. Analyse und klinische Bewertung einer multizentrischen therapiestudie bei 3.470 patienten mit essentieller arterieller hypertonie. Nieren Hochdruckkr 1994; 23: 205
36. 36. Lohmann FW, Lang S, Gotzen R, et al. Der Einfluss einer antihypertensiven therapic auf the zerebrale Durchblutung beim älteren Menschen. Med Welt 1993; 44: 345